Machine Learning Is Enabling A New Era For Precision Medicine And Pharmacogenomics
Machine Learning Is Enabling A New Era For Precision Medicine And Pharmacogenomics
Publish Date: 2026-06-27 12:35:00
Source Domain: www.forbes.com
- AI and machine learning have started to shift the healthcare approach from a generalized to a predictive and genotype-directed model of patient care.
- AI is being used to develop tools in pharmacogenomics, aiding in creating tailored, bespoke, and effective medication and therapeutics with reduced adverse reactions.
- AI-powered machine learning models facilitate early and accurate diagnosis of diseases like cancer, diabetes, and cardiovascular diseases by analyzing complex datasets and medical imaging.
- Machine learning is playing a crucial role in improving precision drug design and therapeutics and has the potential to significantly improve outcomes in various critical speciality areas including psychiatry, cardiology, oncology, and infectious diseases.
- The future of healthcare looks promising with AI potentially transforming diagnostics, precise drug design, personalized therapeutics, remote patient monitoring, follow-ups, and longevity medicine due to ongoing heavy investments in AI technology and rapidly deteriorating health conditions globally.
